Steris (NYSE: STE) insider transactions
In the twelve months to 10 November 2026, executives and directors of Steris reported 12 open-market sales of 39,528 shares ($9.8m) and 0 open-market purchases, by 7 people, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 1 October 2026 | Burton Karen L | Sr. Vice Pres., CFO | Shares withheld for tax | −228 | — | 12,956 | Form 4 |
| 12 August 2026 | Sohi Mohsen | Director | Option exercise | +4,058 | $86.23 | 28,363 | Form 4 |
| 12 August 2026 | Sohi Mohsen | Director | Open-market sale | −4,058 | $235.78 | 24,305 | Form 4 |
| 1 July 2026 | Sohi Mohsen | Director | Option exercise | +3,781 | $71.40 | 26,142 | Form 4 |
| 1 July 2026 | Sohi Mohsen | Director | Shares withheld for tax | −1,837 | $212.30 | 24,305 | Form 4 |
| 15 June 2026 | Zangerle John Adam | Sr. VP, Gen Counsel, and Sec. | Open-market sale, 10b5-1 plan | −1,419 | $209.28 | 35,259 | Form 4 |
| 5 June 2026 | Carestio Daniel A | President and CEO | Open-market sale, 10b5-1 plan | −1,374 | $212.00 | 63,647 | Form 4 |
| 4 June 2026 | Burton Karen L | Sr. Vice Pres., CFO | Shares withheld for tax | −90 | $212.24 | 13,184 | Form 4 |
| 4 June 2026 | Carestio Daniel A | President and CEO | Shares withheld for tax, 10b5-1 plan | −1,889 | $212.24 | 68,075 | Form 4 |
| 4 June 2026 | Carestio Daniel A | President and CEO | Open-market sale, 10b5-1 plan | −3,054 | $214.64 | 65,021 | Form 4 |
| 4 June 2026 | Fraser Mary Clare | SVP & Chief HRO | Shares withheld for tax | −600 | $212.24 | 13,716 | Form 4 |
| 4 June 2026 | Kohler Kenneth E | SVP & Gm, Ast | Shares withheld for tax | −150 | $212.24 | 11,332 | Form 4 |
| 4 June 2026 | Madsen Julia | Sr. VP and GM, Life Sciences | Shares withheld for tax | −195 | $212.24 | 12,257 | Form 4 |
| 4 June 2026 | Tamaro Renato | V.P. & Corporate Treasurer | Shares withheld for tax | −65 | $212.24 | 6,194 | Form 4 |
| 4 June 2026 | Zangerle John Adam | Sr. VP, Gen Counsel, and Sec. | Shares withheld for tax | −401 | $212.24 | 36,678 | Form 4 |
| 3 June 2026 | Burton Karen L | Sr. Vice Pres., CFO | Shares withheld for tax | −190 | $210.19 | 13,274 | Form 4 |
| 3 June 2026 | Carestio Daniel A | President and CEO | Shares withheld for tax | −2,619 | $210.19 | 69,964 | Form 4 |
| 3 June 2026 | Fraser Mary Clare | SVP & Chief HRO | Shares withheld for tax | −311 | $210.19 | 14,316 | Form 4 |
| 3 June 2026 | Kohler Kenneth E | SVP & Gm, Ast | Shares withheld for tax | −184 | $210.19 | 11,482 | Form 4 |
| 3 June 2026 | Madsen Julia | Sr. VP and GM, Life Sciences | Shares withheld for tax | −239 | $210.19 | 12,452 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Steris page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.